12/09/2024
8:49 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
6:11 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
3:43 PM | C4 Therapeutics (Subject)
Salter Malcolm (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
6:53 PM | C4 Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
5:43 PM | C4 Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G | |
11/14/2024
8:01 AM | C4 Therapeutics (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
11/13/2024
11:15 PM | C4 Therapeutics (Filer)
| Form EFFECT | |
|
11/13/2024
11:15 PM | C4 Therapeutics (Filer)
| Form EFFECT | |
11/13/2024
3:57 PM | C4 Therapeutics (Filer)
| Form SUPPL | |
11/13/2024
3:58 PM | C4 Therapeutics (Filer)
| Form SUPPL | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
C4 Therapeutics (Subject)
| Form SC 13G | |
10/31/2024
4:26 PM | C4 Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/31/2024
4:27 PM | C4 Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/31/2024
6:07 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
6:12 AM | C4 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
3:30 PM | C4 Therapeutics (Issuer)
Mahaney Paige (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/29/2024
3:31 PM | C4 Therapeutics (Issuer)
Mahaney Paige (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
C4 Therapeutics (Subject)
| Form SC 13G | |
10/18/2024
3:45 PM | C4 Therapeutics (Subject)
Salter Malcolm (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
3:11 PM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
4:37 PM | C4 Therapeutics (Subject)
Salter Malcolm (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024
3:10 PM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:11 PM | C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | C4 Therapeutics (Issuer)
Schick Kelly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | Adams Kendra (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | Boyle Scott N (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:12 PM | C4 Therapeutics (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:51 PM | C4 Therapeutics (Issuer)
Fawell Stephen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
3:52 PM | C4 Therapeutics (Issuer)
Fawell Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
6:06 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
6:27 AM | C4 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
6:11 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
5:47 AM | C4 Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
06/11/2024
3:45 PM | C4 Therapeutics (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/11/2024
3:46 PM | C4 Therapeutics (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
6:41 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:10 AM | C4 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
6:07 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
7:52 AM | C4 Therapeutics (Filer)
| Form ARS | |
04/29/2024
7:03 AM | C4 Therapeutics (Filer)
| Form DEF 14A | |
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad) The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget!
We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] |
04/29/2024
7:04 AM | C4 Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024
3:16 PM | C4 Therapeutics (Issuer)
Mossler Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:52 AM | C4 Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
03/08/2024
6:28 PM | Boyle Scott N (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:19 PM | C4 Therapeutics (Issuer)
Siegel Jolie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:21 PM | Adams Kendra (Reporting)
C4 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:24 PM | C4 Therapeutics (Issuer)
Schick Kelly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:26 PM | C4 Therapeutics (Issuer)
Fisher Stewart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
12:11 PM | C4 Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
03/04/2024
6:05 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
8:01 AM | C4 Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024
6:15 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:20 AM | C4 Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
5:18 PM | C4 Therapeutics (Issuer)
Hirsch Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:21 AM | C4 Therapeutics (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
02/14/2024
6:35 AM | C4 Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/09/2024
12:04 PM | C4 Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/05/2024
9:24 AM | C4 Therapeutics (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G | |
02/02/2024
8:34 AM | C4 Therapeutics (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
01/12/2024
3:01 PM | Betta Investment Ltd. (0001990727) (Filed by)
C4 Therapeutics (Subject)
| Form SC 13G | |
01/11/2024
6:05 AM | C4 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:15 PM | C4 Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
01/03/2024
3:12 PM | C4 Therapeutics (Issuer)
Dubin Glenn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
3:30 PM | C4 Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
12/22/2023
3:05 PM | C4 Therapeutics (Subject)
COMMODORE CAPITAL LP (Filed by)
| Form SC 13G | |
